Device Trial Radar · NCT03808116
Evaluation of the SmartBx System for Breast Biopsy
Last checked: Nov 20, 2026Latest source record: Nov 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jun 10, 2019
Primary completion
Aug 5, 2019
Study completion Sep 1, 2019
Sponsor
- Lead sponsor
- UC Care, Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 17, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of: 3\. Biopsy core length obtained (i.e. collecting all tissue fragments) 4. Biopsy core yield (i.e. percent of tissue loss during the pathologic processing)
Conditions
- Breast Cancer
Interventions
SmartBxDevice
he SmartBx device is intended for the retention of a biopsy specimen and for preservation of the specimen's in-needle location and orientation. The SmartBx is used as an aiding tool in biopsy procedures. When operated in conjunction with the standard equipment in a prostate biopsy procedure, the SmartBx may be used for the following: * To preserve sample unity, including core fragments in their original location along the needle notch. * Avoid sample damaging during sample removal from the needle and the following pathology process.
Primary outcomes
What the sponsor says the trial is designed to measure.
- biopsy core lengthTime frame: 1 month
- biopsy core yieldTime frame: 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Haemek medical center
Afula, North Region, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.